The gRAMP CRISPR-Cas effector is an RNA endonuclease complexed with a caspase-like peptidase
Author(s) -
Sam P. B. van Beljouw,
Anna C. Haagsma,
Alicia Rodríguez-Molina,
Daan F. van den Berg,
Jochem N. A. Vink,
Stan J. J. Brouns
Publication year - 2021
Publication title -
science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 12.556
H-Index - 1186
eISSN - 1095-9203
pISSN - 0036-8075
DOI - 10.1126/science.abk2718
Subject(s) - effector , endonuclease , crispr , rna , microbiology and biotechnology , chemistry , biology , enzyme , genetics , biochemistry , gene
CRISPR and Caspase meet Many prokaryotes use CRISPR RNA–bound proteins to sense viral RNA instead of DNA to set an immune response in motion that protects from virus infection. Although these ribonucleoproteins are typically composed of many protein subunits, van Beljouwet al . discovered that CRISPR-Cas type III-E systems are formed by a large, single-component effector protein capable of double RNA cleavage. Distinct from other systems, this effector forms a complex with a peptidase from the caspase family, raising the intriguing possibility that viral RNA activates a protease activity to prevent virus propagation by host suicide. —DJ
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom